Exogenous Visual Orienting Is Associated with Specific Neurotransmitter Genetic Markers: A Population-Based Genetic Association Study by Lundwall, Rebecca A. et al.
Exogenous Visual Orienting Is Associated with Specific
Neurotransmitter Genetic Markers: A Population-Based
Genetic Association Study
Rebecca A. Lundwall
1*, Dong-Chuan Guo
2, James L. Dannemiller
1
1Psychology Department, Rice University, Houston, Texas, United States of America, 2Department of Internal Medicine, University of Texas Health Science Center,
Houston, Texas, United States of America
Abstract
Background: Currently, there is a sense that the spatial orienting of attention is related to genotypic variations in
cholinergic genes but not to variations in dopaminergic genes. However, reexamination of associations with both
cholinergic and dopaminergic genes is warranted because previous studies used endogenous rather than exogenous cues
and costs and benefits were not analyzed separately. Examining costs (increases in response time following an invalid pre-
cue) and benefits (decreases in response time following a valid pre-cue) separately could be important if dopaminergic
genes (implicated in disorders such as attention deficit disorder) independently influence the different processes of
orienting (e.g., disengage, move, engage).
Methodology/Principal Findings: We tested normal subjects (N=161) between 18 and 61 years. Participants completed a
computer task in which pre-cues preceded the presence of a target. Subjects responded (with a key press) to the location of
the target (right versus left of fixation). The cues could be valid (i.e., appear where the target would appear) or invalid
(appear contralateral to where the target would appear). DNA sequencing assays were performed on buccal cells to
genotype known genetic markers and these were examined for association with task scores. Here we show significant
associations between visual orienting and genetic markers (on COMT, DAT1, and APOE; R
2s from 4% to 9%).
Conclusions/Significance: One measure in particular – the response time cost of a single dim, invalid cue – was associated
with dopaminergic markers on COMT and DAT1. Additionally, variations of APOE genotypes based on the e2/e3/e4 alleles
were also associated with response time differences produced by simultaneous cues with unequal luminances. We conclude
that individual differences in visual orienting are related to several dopaminergic markers as well as to a cholinergic marker.
These results challenge the view that orienting is not associated with genotypic variation in dopaminergic genes.
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Introduction
Attention can be directed to spatial locations either voluntarily
(endogenous cueing) or reflexively (exogenous cueing). There is
currently a sense that the reflexive aspect of attentional orienting is
related to cholinergic neurotransmitter genes but only weakly or
not at all to variations in dopaminergic genes [1,2]. However,
many of the previous studies showing associations with cholinergic
genes used endogenous cues to direct attention spatially, so it is at
least possible that the use of exogenous cueing to produce more
reflexive orienting might result in additional associations with
dopaminergic genes. Additionally, the costs and benefits of using
invalid and valid spatial cues, respectively, were not analyzed
separately in these previous experiments. Examining costs
(increases in response time, RT, following an invalid pre-cue)
and benefits (decreases in RT following a valid pre-cue) separately
could be important if dopaminergic genes (implicated in disorders
of attention such as attention deficit disorder; ADHD) influenced
the different processes of attentional orienting independently (e.g.,
disengaging, moving, re-engaging attention; [3]).
Visual orienting is impaired in many heritable disorders
including Alzheimer’s disease, autism, and schizophrenia [4–7].
Genes control the synthesis, transportation, conversion, and
metabolism of neurotransmitters and therefore offer plausible
biological pathways for understanding these disorders. Both
dopamine [8] and acetylcholine [9] have been implicated in
attention processes generally. In this paper we examine possible
associations between several genetic markers (‘‘markers’’) and
visual orienting using a modification of Posner and Cohen’s
exogenous cued orienting task [10]. In addition, we tested the
hypothesis that genetic associations with visual orienting might
only be detected when attentional costs and benefits are analyzed
separately rather than combined into a single validity score (e.g.,
mean benefit minus mean cost).
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e30731Although visual orienting is an important component of many
heritable disorders, studies have not always found genetic associa-
tions with orienting. For example, Fan et al., [11] failed to find
significant heritability for visual orienting in a twin study. However,
their task did not use invalid cues to calculate the cost component of
exogenous orienting. We feel that it is important to test genetic
associationswiththisaspectoforienting.Posner,Walker,Friedrich&
Rafal [3] described three steps in orienting: engage, disengage, and
move. Looking at costs and benefits separately allows for
examination of possibly separate genetic influences on all three
aspects of orienting as proposed by Posner and colleagues. The
responsetoatargetfollowingavalidpre-cueonlyrequirestheengage
function since attention is already at that location. In particular,
lower availability of dopamine (as determined by genotype) could
lead to significantly larger costs because the availability of dopamine
could impact the rapid reorienting of attention.
In addition to the Fan et al., study [11], a more recent review
notes that associations between dopaminergic genes and orienting
have generally been lacking [1]. In contrast, associations between
visual orienting and cholinergic genes have been found in normal
populations [2,12]. Like the differences between tasks described
above, the tasks in these studies were also somewhat different from
the current task in that we used exogenous cues, while the tasks of
Espeseth et al., [12], Fan et al., [11], and Parasuraman et al., [2]
used endogenous cues. Here, we re-examined possible relations
between exogenously-cued (reflexive) visual orienting and several
genetic markers (one cholinergic, one noradrenergic, and three
dopaminergic). The noradrenergic gene, dopamine beta hydrox-
ylase (DBH), is related to dopamine in that it converts dopamine to
norepinephrine (noradrenaline). We added several conditions (see
below) to the standard cued-orienting procedure in an attempt to
employ more sensitive behavioral measures of orienting in the
genetic association analysis.
We reasoned that if costs and benefits were even partially
determined by distinct neural mechanisms, then this would argue
for separate analysis when searching for genetic associations.
Treating costs and benefits separately would be consistent with
Posner’s formulation of orienting as a three-step process in which
disengaging attention is necessary for invalid but not for valid cues.
Genetics and Visual Attention
There are several ways to select genes for study. One method,
genome-wide association, scans the entire genome for association
with a phenotype. This is potentially problematic because it
increases the risk of Type I errors unless very large sample sizes are
used. One way to avoid this problem is to select candidate DNA
markers based on biological pathways such as those that control
key neurotransmitters [13]. In selecting genetic markers, we
searched the literature and considered genes that controlled
neurotransmitter availability and/or were associated with diseases
having an attentional component.
We narrowed this list to the current selection of markers based
on such factors as the availability of a precise marker location
(such as a ‘reference SNP;’ single nucleotide polymorphism), the
allele in question having a known impact on biological function, a
moderate to large effect size, and/or the existence of a
relationship with a disease having a purported reflexive orienting
component.
In planning our analysis, we tried to avoid common problems in
genetic association studies. One challenge is that variation on a
single marker rarely accounts for more than 5%–10% of the
variance in a complex phenotype which may be influenced by
many genetic and environmental factors. This will make the
association statistically difficult to detect without large sample sizes
[14] or very precise measures. One way to increase precision is to
use endophenotypes (specific phenotypic measures) rather than
more global constructs [15]. We used outcomes derived to
measure specific aspects of visual orienting. In addition to
standard orienting, we also examined alerting, another aspect of
attention, but found no significant associations. In the selection of
genetic markers, we also examined prior research for biological
and functional effects (see Table 1). Both the use of endopheno-
types and careful selection of genetic markers increased the
likelihood of finding valid associations.
Another problem (stratification) occurs when there are system-
atic differences in a phenotype that have nothing to do with the
marker under study, yet the association appears statistically
significant. These spurious associations can arise when ethnic
groups are combined in the same study, differ on a phenotype and
simultaneously differ for unrelated reasons on the target genotype
frequencies. To address this problem we controlled for ethnicity in
the statistical analyses ([16]; see also the Discussion section).
Additionally, unlike genome-wide scans in which no a priori
markers have been selected, we specifically chose the markers in
the present research for their known biological or functional effects
thus reducing the risk of spurious associations.
Table 1. Biological and Functional Effects of Genetic Markers in this Study.
Genetic Marker Risk Allele Biological Effect Functional Effect
COMT rs4680 G G at rs4680 produces valine which is more active in
catabolizing dopamine and so less dopamine is available [18].
Reduced cognitive function [18].
DAT1 intron 8 VNTR 6R 6R leads to more dopamine transporter and therefore
less dopamine in the synapse [20], and this terminates
the dopaminergic signal transmission [21].
Greater cuing costs for targets in the left
hemifield [19].
DRD4 rs747302 C C leads to fewer dopamine receptors via reduced
transcription [27].
There is an association between
rs747302 and ADHD [27].
APOE e4 e4 reduces acetylcholine receptor number [25] and
possibly diminished synthesis of acetylcholine via impaired
regulation of phospholipids and/or fatty acid transport [26].
Middle age, nondemented carriers of e4
showed deficits in spatially cued visual
tasks [23].
DBH rs1108580 A DbH converts dopamine to norepinephrine and the A allele
is associated with lower levels of plasma DbH [28] and
therefore lower norepinephrine to dopamine ratios [53].
Lower levels of plasma DBH activity
have been associated with attention
deficit [28].
Note. Bellgrove et al. [19] refer to 3R but according to Rommelse et al. [22] 3R is now called 6R.
doi:10.1371/journal.pone.0030731.t001
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association with visual orienting. The markers were: COMT
Val158Met (NM_000754.3; a SNP, rs4680; [17,18]), DAT1
(SLC6A3; NM_001044.4; a 30 bp VNTR on intron 8; [19–22]),
and APOE (NM_000041.2; a two SNP composite, rs429358 and
rs7412; [23–26]), DRD4 (NM_000797.3; a SNP, rs747302; [27])
and DBH (NM_000787.3; a SNP, rs1108580; [28,29]). Although
the SNP in DBH showed no significant associations with any of the
attention measures, we included it in this report because it shows
that not all markers related to dopamine were associated with our
attentional measures. (See Table 1 for more details on the
biological and functional rationale for selecting these genetic
markers).
Results
We only included data in the following analyses from subjects
who made errors on 5% or fewer of the 200 experimental trials. In
addition, only a subject’s correct trials were included. An average
of 1.44% of trials were excluded due to error.
As stated previously, the derived measures used in the analyses
are difference scores. All derived measures were significantly
different from zero with the exception of benefit dim (p=.98) and
dual asymmetric cost bright (p=.42), and all of the derived measures
were in the expected direction (that is, benefits were positive and
costs were negative; with an average SEM=2.30 msec). Thus, the
basic paradigm produced significant cueing effects including the
standard alerting effects as well as costs and benefits from invalid
and valid cues, respectively. We also found, as Kean and Lambert
[30] did, that when bright and dim cues appeared simultaneously
in contralateral spatial locations, subjects responded more quickly
(by 23.93 msec, SEM=1.92 msec) to a target when it appeared
near the location of a preceding brighter cue than when it
appeared near the location of the dimmer cue. Thus, our use of
dual asymmetric luminance cues produced the expected RT
difference.
One of the key questions in this study was whether RT costs and
benefits were correlated. There was a statistically significant
correlation between benefit bright and cost bright (r=.28, p=.001)
and, likewise, between benefit dim and cost dim (r=.23, p=.01).
Because benefits are coded positively and costs are coded
negatively, these correlations indicate that larger costs were
associated with smaller benefits. The magnitudes of these
correlations of costs and benefits indicate that only 7.78% of the
variance in benefits based on bright cues and 5.51% of the variance
in benefits based on dim cues is explained by knowing the
corresponding cost measure. We took this as support for treating
costs and benefits separately in the subsequent genetic association
analyses rather than combining them into a single validity score.
Genetic Associations
Because we had 10 outcome measures, we initially conducted a
MANCOVA with age and ethnicity as covariates and all five genes
as predictors. We used Roy’s largest root to determine statistical
significance because of the high inter-correlations between the
dependent variables and because the first canonical variate for
each gene explained a high percentage of the variance in the
outcome measures (greater than 72%). Four of the five genes were
statistically significant after controlling for age and ethnicity:
DRD4 (F[10, 86]=1.89, p=0.06); DAT1 (F[10, 86]=2.64,
p=0.007); COMT (F[10, 86]=2.27, p=0.02); DBH (F[10,
86]=0.77, p=0.65); and APOE (F[10, 86]=1.96, p=0.047).
The remaining analyses were conducted as described in the
methods section. That is, an initial ANOVA was used with
ethnicity as an independent variable to control statistically for
possible population stratification artifacts. To test for genetic
associations, genotype was then added as another independent
variable, and the incremental R
2 was obtained.
DAT1 (30 bp VNTR on intron 8) was associated significantly with
costdim(R
2change=8%, F[1, 124]=11.97, p,.001) but not with the
cost bright (p=.46) or benefit dim measures (p..99). Cost bright and benefit
dim p-values are provided for comparison purposes as the lack of
significance for these measures suggests the importance of including
separate analyses of both costs and benefits and of cue luminance
levels. The 6-repeat/6-repeat (6R/6R) genotype at this location was
associated with larger costs following invalid dim cues (Figure 1).
COMT (rs4680) was also associated significantly with the cost dim
measure (R
2 change=4%, F [1, 129]=5.40, p=.02) meaning the
GG genotype (Val/Val) at this location was associated with larger
costs following invalid dim cues. Benefit dim likewise showed
significant association (R
2 change=3%, F [1, 129]=3.97,
p=.048; Figure 2), but cost bright did not (p=.60). Dual asymmetric
cost dim did not reach conventional significance levels (R
2
change=2%, F [1, 129]=2.93, p=.09) but is reported here as a
guide to future research.
Those with the e2/e3 genotype of APOE were faster at
responding following bright than dim cues, as measured by
congruence benefit, in contrast to those with e3/e3 or the combined
e3/e4 and e4/e4 genotypes (Figure 3). The differences are
significant, R
2 change=5%, F(1, 120)=6.88, p=.01. Congruence
benefit measures the extent to which subjects respond faster to a
target when it appears near the brighter of two simultaneous cues
placed symmetrically with respect to fixation [30]. It is not possible
to detect this effect with a single cue paradigm. Alert bright did not
reach conventional significance levels, R
2 change=2%, F(1,
120)=2.61, p=.11.
Alert bright showed a weak association with genotype on DRD4,
R
2 change=3%, F[1, 119]=3.37, p=.07. Neither benefit dim (R
2
change=2%, F[1, 119]=2.11, p=.15) nor cost dim (R
2
change=2%, F[1, 119]=2.56, p=.11; Figure 4) reached
conventional significance levels by genotype on DRD4. However,
those with the GG genotype tended toward less of a cost to a dim,
invalid cue than those with CG or CC genotypes. They also showed
greater benefits to a dim, valid cue than those with the CC
genotype. Table 2 summarizes these effects.
Finally, no significant results were found for DBH.
Discussion
The results lead to three conclusions. First, the luminance of a
cue significantly influenced the likelihood of observing an
association between a genetic marker and specific attentional
measures. Second, attentional costs and benefits should be
analyzed separately when examining genetic associations. The
alternative, combining them into a single validity score, runs the
risk of missing differential genetic associations on these alternate
measures of visual orienting. Third, in contrast to several previous
studies, we find that dopaminergic markers on DAT1 and COMT
showed significant associations with specific orienting measures.
APOE also showed a significant association with a specific
orienting measure. We will elaborate briefly on these conclusions.
In the case of our conclusion regarding luminance, we note that
for DAT1 and COMT cost dim reached significance, but cost bright
did not. This suggests that the luminance of the cues matters in
assessing gene-attention associations. Consider several explana-
tions for this result. First, it should be noted that RT variance was
approximately equal at the two cue luminance levels, thus ruling
out reduced RT variance as an explanation for the lack of an
Visual Orienting Associations with Genetic Markers
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that the luminance of the target was always the same in all
conditions; it was only the luminance of the cues that differed.
Second, consider the possibility that dim cues might require more
attentional effort thereby recruiting executive aspects of attention.
This does not seem likely because subjects were dark adapted, and
the dim cues were clearly visible, although obviously dimmer than
the bright cues (luminance ratio 5.85:1). We also note that subjects
were explicitly instructed to ignore the cues because they did not
predict the location of the target across the set of trials. Under
these circumstances, it seems unlikely that differences in cue
luminance would have exerted their effects by requiring more or
less attentional effort.
Third,considerthepossibilitythatthevaliditymanipulation might
have induced conflict processing, also recruiting more executive
aspects of attention. Specifically, including invalid trials means that
on sometrialsthereis a conflictbetween the location ofa cue andthe
location of a target, while on other trials there is not. Nevertheless,
even though cues do not predict the location of the target (that is,
cues are 50% valid and 50% invalid) the task clearly taps reflexive
processes since it still produces the expected costs and benefits.
Conflict processing is unlikely to be involved because exogenously
cued orienting is generally regarded as being reflexive [31–33].
There is some empirical evidence that the level of dopamine
interacts with cue intensity to determine reactions times. On the
sensory side, dopamine release is influenced by stimulus intensity
at early stages in the visual system [34,35]. On the attentional side,
Rihet, Possamaı ¨, Micallef-Roll, Blin, & Hasbroucq [36], in
particular, showed that when levodopa versus a placebo was
administered to subjects, RT decreased more (i.e., the difference
was greater) with weak intensity cues than with strong intensity
cues. In other words, weak intensity cues were better at revealing
the impact of a dopamine agonist on RT. This is very similar to
our results in the sense that when we found associations with
dopamine related markers it was only with our low intensity (dim)
cues.
When we examined the costs for bright versus dim cues with the
COMT gene, we found an interesting pattern of results that could
explain why the intensity of a cue matters when testing for genetic
associations. The intensity of an invalid cue did not affect the time
that it took subjects with the GG (less dopamine) genotype to
respond to the appearance of the target on the side contralateral to
the cue; the average costs relative to their respective neutral
baseline conditions were approximately 30–35 msec regardless of
the intensity of the cue. Interestingly, subjects with the AA (more
dopamine) genotype also showed an average cost in this same
range (32 msec) when a bright, invalid cue was used. In contrast,
subjects with the AA genotype showed an average cost (18 msec)
that was approximately half as large when a dim, invalid cue was
used. It should also be noted that within each of these genotypes
Figure 1. Mean cost dim difference scores by DAT1 genotype. Note that the 5R/5R genotype group had only 6 subjects and the mean may,
therefore, not be reliable. This graph represents the mean after adjustment for ethnicity. Error bars are +/21 SEM.
doi:10.1371/journal.pone.0030731.g001
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of the cues when neutral cues were used (that is, two, equal
luminance cues presented simultaneously). This shows that those
with the AA genotype on COMT are able to disengage and shift
attention more quickly than those with the GG genotype but only
when weaker invalid cues are used. For both genotypes, the costs
were approximately the same when a stronger invalid cue was used,
so the result cannot simply be attributed to a superior overall
ability of those with the AA genotype to disengage attention from
an invalid cue more quickly. This suggests that the reason that we
observed genetic associations with attentional costs when dim cues
were used but not when bright cues were used is that the level of
available dopamine only has an effect on how long weak cues
distract or hold attention. Apparently, those with the GG genotype
on COMT are just as distracted by these weak, irrelevant cues as
they are by the stronger ones while those with the AA genotype are
less distracted by weaker cues.
To understand these results, assume a simple model like that
considered by Luce and Green [37] of how subjects make a forced-
choice, speeded decision that results in a right vs. left response to
the target. To make this decision about the side on which the
target appeared, subjects are assumed to sample incoming neural
information from the regions around the two locations in which
the target can appear. Once sufficient information has been
accumulated to allow the subject to discriminate these two
samples, the decision is reached, and the subject responds right
vs. left. A critical aspect of the model proposed by Luce and Green
[37] is that the subject must start this process of sampling neural
information from the two likely target locations at some point in
time relative to the onset of the target. If one assumes that the
appearance of the cue automatically biases the subject to start
sampling from the possible target location ipsilateral to the cue
earlier than from the contralateral location, then one would expect
faster RTs when the target subsequently appeared on the side
ipsilateral to the cue and slower RTs when the target appeared on
the side contralateral to the target, thus producing the typical
pattern of costs and benefits. Notice, however, that because the
cues are completely uninformative in a design like the one that we
used, these automatic biasing effects would only be helpful (in
terms of the latency to respond to a target) if the benefits were on
average greater than the costs. In our data, the costs were typically
larger than the benefits for a given cue intensity, so being able to
ignore these cues, or being able to disengage from them more
quickly to start sampling from both target locations simultaneously
Figure 2. Mean cost dim benefit dim, and dual asymmetric cost dim difference scores by COMT genotype. This graph represents means
after each measure was adjusted for ethnicity. Error bars are +/21 SEM.
doi:10.1371/journal.pone.0030731.g002
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show that subjects with the AA genotype on the COMT come
closer to being able to ignore or to disengage more quickly from
weak, irrelevant (distracting) cues than do subjects with the GG
genotype. Apparently, this must be more difficult to do when
stronger peripheral cues are used because both genotypes
showed approximately the same attentional costs under those
conditions.
This result is similar, but not identical, to an effect discussed by
Nissen [38] showing that target intensity had an effect on
attentional costs but not on attentional benefits such that costs
were greater with lower intensity targets than with higher intensity
targets. Nissen concluded that when intensity had an effect in these
cueing paradigms, it tended to be on the attentional mechanisms
rather than on the sensory pathways. While our effect involved the
intensity of the cues rather than of the targets, the two sets of results
are similar in that when intensity exerted an effect, in both cases
the locus of the effect appeared to be at the level of attention rather
than at the level of the sensory pathway, and the effect was
observed with attentional costs but not with attentional benefits.
In addition to suggesting the importance of luminance, the fact
that, for DAT1, cost dim is significant but benefit dim is not argues for
separating costs and benefits. Had we used only a validity score,
we would have missed the fact that benefits and costs were
differentially associated with individual differences in various
intake measures (e.g. age, ethnicity, and tobacco use; see Table 3)
as well as with genotypic variation on DAT1. That costs and
benefits should be separated is also suggested by their low
correlations (mentioned above; see Table 4). This is despite the
fact that each was calculated as a difference from the same baseline
measure (RT to dual neutral cues). When the cost of attending to
an invalid cue is not separated from the benefit of attending to a
valid cue, then the single validity measure could be less sensitive in
detecting subtle individual differences. Using a combined validity
measure provides inherently less information.
We also note that the percentage of variance on cost dim that was
statistically explained by variance on benefit dim, 5%–7%, is
approximately the same magnitude as the percentage of variance
explained by the genetic markers that were statistically significant.
In other words, knowing a subject’s genotype on a particular
Figure 3. Mean congruence benefit and alert bright difference scores by APOE genotype. With two SNPs contributing to APOE status, there
are six possible groups. We organized these into groupings as did others [23], however we modified the groups by eliminating subjects who had one
risk allele (e4) and one protective factor (e2) (n=2) since a hypothesis for the outcome in such individuals was unclear [24]. The sample size for the
e2/e3 genotype is relatively small, but represents a naturally occurring group with a putative protective factor. The e2 allele is relatively rare. For
example, in a sample of 5000 alleles from 2500 subjects only 7.65% of the alleles were e2 [24]. This graph represents means after adjustment for
ethnicity. Error bars are +/21 SEM.
doi:10.1371/journal.pone.0030731.g003
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knowing that subject’s benefit measure. We find it remarkable that
genetic information does approximately as good a job at predicting
a subject’s behavioral measure as does another contemporaneously
collected behavioral measure on that same subject.
Our third conclusion is that DAT1, COMT, and APOE each
showed significant associations with specific attentional measures
derived from this visual orienting paradigm (neither DBH nor
DRD4 reached conventional significance levels). The cost dim
measure was particularly useful in this regard. These significant
genotype-phenotype associations stand in contrast to previous
reports showing associations for more executive aspects of
attention but not for orienting [11,39] or those that suggest that
cholinergic genes are associated with orienting but dopaminergic
genes are not [1,2]. One caution to this conclusion is that some of
the dopaminergic markers that we studied could affect cholinergic
processes and thus exert their effects indirectly [40]. Further
research is needed to clarify this issue.
Figure 4. Mean cost dim, benefit dim, and alert bright difference scores by DRD4 genotype. This graph represents means after adjustment
for ethnicity. Error bars are +/21 SEM.
doi:10.1371/journal.pone.0030731.g004
Table 2. Effect Sizes (R
2 change) for Significant Associations after Controlling for Ethnicity.
Genetic Marker N Measure R
2 change F(1, error df complete) p-value
DAT1 30 bp VNTR on intron 8 131 cost dim 0.09 12.71 (1, 126) ,.0001
COMT rs4680 136 cost dim 0.04 5.57 (1, 131) 0.02
COMT rs4680 136 benefit dim 0.03 4.17 (1, 131) 0.04
APOE rs429358 & rs7412* 127 congruence benefit 0.05 6.95 (1, 122) 0.01
DRD4 rs747302 126 cost dim 0.02 2.44 (1, 121) 0.12
DRD4 rs747302 126 benefit dim 0.02 2.53 (1, 121) 0.11
Note. APOE status is determined jointly by two SNPs.
doi:10.1371/journal.pone.0030731.t002
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association studies. However, we think it unlikely that our results are
entirely spurious for several reasons. First, there is both a plausible
biologic pathway between dopamine availability and attention and
a dose-response relationship in our data (tested with our linear
model). These are often considered the minimum requirements in
searching for legitimate associations [41–43]. Second, with two of
the four markers for which we found significant associations, the
same behavioral measure, cost dim, proved significant. Had our
results beenprimarily Type I error, the statistically significant effects
most likely would have been randomly distributed across the
behavioral measures. Third, because the markers that we selected
for analysis were chosen based on prior association with attention,
our findings (including the direction of observed effects following
putative risk) can be considered a constructive replication.
Replication is unlikely if the results are spurious.
Population stratification is a potential problem precisely because
it may lead to an increased type I error rate, but it deserves
additional consideration. First, absent gene-gene and/or gene-
environment interactions, knowledge of a biological pathway can
be helpful in reducing the risk of threats to validity from
population stratification. For other reasons, however, our results
are unlikely to be due to population stratification. Recall that, for
population stratification to exist, substantial phenotypic differences
must be present between ethnic groups [44]. However, there is not
significant inter-ethnic variation in the cost dim measure; therefore
the current findings are unlikely to be the result of population
stratification. Several authors have determined that even in cases
where conditions exist that make population stratification a
possibility, potential bias remains small [45,46]. Nevertheless, we
statistically controlled for ethnicity which has been shown to be
effective [16].
Table 3. Correlations between Intake Variables and Outcome Measures.
Variable AB AD BB BD CB CD CongB DACB DACD DBTN VEbright VEdim
Location 20.07 0.00 20.16* 20.12 0.04 0.06 0.37*** 0.32*** 20.15* 20.11 20.17* 20.14*
Age 20.05 0.00 20.19* 20.16* 0.02 0.05 0.22* 0.25** 20.03 20.07 20.17* 20.17*
Gender 0.04 20.01 0.02 0.10 0.15* 0.13 20.13 0.03 0.08 0.00 20.12 20.01
Asian 20.03 20.12 0.08 0.15* 20.12 0.00 20.25** 20.23** 0.07 0.19* 0.17* 0.13
Black 20.12 20.15* 20.02 0.02 20.05 20.17* 0.05 0.04 20.03 0.06 0.03 0.14*
Hispanic 20.01 20.01 20.02 20.01 20.20* 20.14 20.06 20.02 0.03 0.21* 0.15* 0.09
sleepiness 0.09 0.15* 0.03 20.14 0.02 20.10 20.02 20.02 0.08 20.02 0.00 20.04
tobacco 20.02 0.02 20.18* 20.06 0.02 20.06 20.09 0.15* 0.09 20.10 20.16* 0.00
Note. AB=Alert Bright; AD=Alert Dim; BB=Benefit Bright; BD=Benefit Dim; CB=Cost Bright; CD=Cost dim; CongB=Congruence Benefit; DACB=Dual Asymmetric
Cost Bright; DACD=Dual Asymmetric Cost dim; DBTN=Dim Better Than Nothing; VEdim=Validity Effect Dim; and VEbright=Validity Effect Bright. Asian, Black and
Hispanic ethnicities are each compared to the White ethnicity.
*=p,.10;
**=p,.01; and.
***=p,.001.
doi:10.1371/journal.pone.0030731.t003
Table 4. Inter-Correlations between Outcome Measures.
Measure AB AD BB BD CB CD CongB DACB DACD DBTN VEbright VEdim
AB 1 0.77*** 20.28* 20.03 20.27** 0.09 20.16* 20.16* 0.11 0.04 0.01 20.09
AD 1 20.06 20.40*** 0.07 20.16* 20.21* 20.13 0.21* 20.03 20.11 20.21*
BB 1 0.18* 0.28** 20.12 0.09 20.69*** 20.25** 20.12 0.56*** 0.24**
BD 1 20.19* 0.23** 0.11 20.26** 20.65*** 0.00 0.31*** 0.66***
CB 1 0.19* 20.12 0.05 0.16* 20.56*** 20.64*** 20.31***
CD 1 20.03 0.07 0.04 20.29** 20.26** 20.59***
CongB 1 0.29** 20.55*** 20.28** 0.18* 0.12
DACB 1 0.24** 0.05 20.60*** 20.27**
DACD 1 0.19* 20.34*** 20.59**
DBTN 1 0.39*** 0.23**
VEbright 1 0.46***
VEdim 1
Note. AB=Alert Bright; AD=Alert Dim; BB=Benefit Bright; BD=Benefit Dim; CB=Cost Bright; CD=Cost dim; CongB=Congruence Benefit; DACB=Dual Asymmetric
Cost Bright; DACD=Dual Asymmetric Cost dim; DBTN=Dim Better Than Nothing; VEdim=Validity Effect Dim; and VEbright=Validity Effect Bright. p-values are below
each correlation. N=143. Costs are coded negatively.
*=p,.10;
**=p,.01; and.
***=p,.001.
doi:10.1371/journal.pone.0030731.t004
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with specific measures designed to study visual orienting. These
results stand in contrast to those of others [11] who concluded that
visual orienting shows little heritability. It is possible that the use of
weaker cues produced a more sensitive measure of orienting,
thereby allowing us to detect these subtle genotype-phenotype
associations.
Materials and Methods
Ethics Statement
The Institutional Review Board of Rice University approved
this study. Written consent was obtained from each participant
prior to the experiments, and the experiments adhered to the
principles found in the Declaration of Helsinki.
Participants
We tested normal subjects (N=161) between the ages of 18 and
61 years (69 males). Most of the participants (n=108) were Rice
University students. A community sample was also obtained
(n=53) to increase the age range of the total sample. Prior to
completing the visual orienting task, subjects signed a consent form
and completed an intake questionnaire that included questions on
basic demographics, attentional disorders in self and biological
relatives, tobacco use, and the Epworth Sleepiness Scale [47].
Based on the distribution of error rates, a subject’s data were
excluded from analysis if they had greater than 5% errors
(including catch trial errors). It makes sense to exclude those
subjects who have high error rates because it indicates that they
might not be motivated or might not have understood the task.
The median error rate for those subjects whose data were
excluded was 9% (range=6%–31%). A subject’s data were also
excluded if they had a history of a serious neurological disorder.
The data from two subjects (both from the community sample)
were discarded because of a history of a neurological disorder.
Subjects were not excluded if they had a current diagnosis of
ADHD. Eight subjects reported this diagnosis, four of whom were
on medication. The pattern of results was substantially the same
when the analyses were run without these subjects and so we
included them. Ninety-one of 108 participants in the Rice
University sample had useable data (45.05% male) as did 46 of
the 53 community participants (43.48% male). Overall, 85.09% of
the subjects had useable data and the final sample consisted of 137
subjects. The mean age for the university sample was 20.52 years
(range 18 to 44 years), and for the community sample it was 35.11
years (range 18 to 61 years). Age did not make a difference in the
results (see Results section).
Behavioral Task Procedures and Stimuli
Participants were dark adapted before beginning the behavioral
task and completed 20 practice trials before beginning data
collection trials. They viewed a 10246768 pixel CRT monitor
with a background luminance of 0.08 cd/m
2. A fixation cross,
centered on the monitor, was always visible. Participants were
instructed to fixate the central cross and to maintain fixation
throughout data collection.
We used both single and dual spatial pre-cues. Dual (bilateral)
cue conditions were similar to those used by Kean and Lambert
[30]. Kean and Lambert showed that observers were faster to
saccade to a target that appeared near the brighter of two
simultaneously presented, but spatially separated pre-cues com-
pared to when the target appeared near the dimmer of the two
cues. We added these dual, unequal cue luminance trials to the
standard single cue conditions (both valid and invalid) because we
hypothesized that they might be more sensitive to individual
differences in the ability to split attention or allocate attention to
differentially salient locations. To provide baseline results against
which to compare these dual, unequal cue luminance trials, we
also included single cue trials using either the brighter or the
dimmer of the cues. We fixed the cue-target stimulus onset
asynchrony (SOA) at 150 msec based on pilot testing of the dual
asymmetric cues. This SOA is also in line with prior literature on
exogenously cued orienting [32,48–50]. Otherwise, the luminanc-
es, sizes, timing, and location of our stimuli were identical to those
reported in Kean and Lambert [30].
One or two cues were presented for 67 msec. The cues could be
valid (i.e., appear where the target would subsequently appear) or
invalid (appear contralateral to where the target would subse-
quently appear). There was an 83 msec gap after the offset of the
cues and prior to the onset of the target. The target remained on
display for 1000 msec or until the participant made a key press (see
Figure 5). Participants were asked to respond as quickly as possible
while maintaining accuracy by making a key press to indicate a
target either to the left (pressing ‘a’) or to the right (pressing ‘l’) of
fixation. After the participant responded, there was a variable
delay (1.3 to 1.8 sec), and the next trial began. No feedback was
provided.
Single cue trials were intermixed with catch, dual neutral, and
dual asymmetric cue trials. The side on which the cue appeared
(for single trials) or on which the brighter cue appeared (for dual
asymmetric cue trials) was random, and each appeared on the
right side of the display for 50% of the trials. The target also
appeared randomly on half the trials on the right side of the
display independently of where the cues appeared. Participants
were told 1) that the cues did not predict the target’s location and
2) to ignore the cues as much as possible. Participants completed
all trials within one session with pauses as necessary. RT was
measured from the onset of the target.
Dual asymmetric cues comprised two cues of unequal
luminance presented on either side of fixation. The brighter and
dimmer cue luminances were 11.7 and 2.0 cd/m
2, respectively.
The target (a square) always had a luminance of 15.5 cd/m
2. The
centermost edge of the target appeared 5.5 deg to either side of the
fixation cross. The cues were shaped like the letter X, measured
0.8 (width)61.0 (height) deg, and appeared 7.3 deg (innermost
edges) to the left and right of the display’s center.
Primary measures. There were nine primary RT measures.
These measures were computed as the average RT (msec) for
correct responses to different cue-target conditions. Single dim valid
indicates a single, dim luminance cue followed by a target near
where the cue was presented. The term ‘valid’ indicates that the
target appeared near that location shortly after the offset of the
cue. Conversely, the configuration termed single dim invalid
indicates a dim cue followed by a target on the side
contralateral to where the cue was presented. There were
corresponding valid and invalid configurations for the single bright
cues. We also included neutral bright and neutral dim cues. On these
trials, identical bright or dim cues were presented simultaneously
on both sides of the fixation cross. These spatially neutral cues
were used to calculate alerting effects. When the dual asymmetric
cues were presented, the target could appear either near the
brighter cue (dual asymmetric bright) or near the dimmer cue (dual
asymmetric dim). Finally, targets could appear uncued without being
preceded by any cues. Catch trials were also presented, and
subjects were instructed to withhold responding since no target
appeared.
Incorrect responses, responses made before 200 msec or after
1000 msec from the onset of the target and responses to catch and
Visual Orienting Associations with Genetic Markers
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(nine target-present plus one target-absent) conditions was
presented 20 times, yielding 200 trials. For analysis, the subject’s
mean RT to correct trials was determined separately for each of
the nine target-present conditions.
Derived measures. We derived 10 measures by computing
within-subject differences between selected pairs of the primary
measures. Three of these are standard measures in a Posner-type
cueing paradigm: alerting, costs, and benefits. Costs, however,
were coded negatively because we felt this better reflects the
different direction of the effect on RT. The use of two different cue
luminances yielded six of these three standard, derived measures.
We derived four additional measures by using trials in which the
dual, asymmetric luminance cues appeared. Table 5 shows the
differences between primary measures that produced these 10
derived measures. These measures served as the endophenotypes
in the association analyses.
Procedures for Genotyping
Participants produced a saliva sample of approximately 2 ml in
an Oragene-250 kit (DNA Oragene, Kanata, Ontario, Canada).
DNA sequencing assay was performed to genotype known SNPs
(see Table 6). Polymerase chain reaction (PCR) amplifications
were carried out using HotStarTaq
TM DNA polymerase (Qiagen
Inc., Valencia, CA). PCR products were treated using Exo_SAP
Figure 5. Illustration of stimuli: The fixation cross was visible throughout a trial. A pre-cue condition appeared for 67 msec. Conditions a)
no cue and b) dual cues of a single luminance were used as baseline conditions for the calculations of derived measures as described in Table 1.
Otherwise, either one or two cues of different luminances appeared. A single target as in condition c) could appear on either the left or right side with
50% probability and could be either bright or dim (50% probability each). The target that followed could appear near where the pre-cue had
appeared or contralaterally. If two cues appeared as in condition d) then the bright cue would appear on the left side for 50% of these trials. After the
cue condition disappeared, a single target followed and could appear near the dim or the bright cue.
doi:10.1371/journal.pone.0030731.g005
Table 5. The Calculation of Derived Measures.
Derived Measure Primary Measures Used in Calculation
Alert Bright No Cue - Neutral Bright
Alert Dim No Cue - Neutral Dim
Benefit Bright Neutral Bright - Single Bright Valid
Benefit Dim Neutral Dim - Single Dim Valid
Cost Bright Neutral Bright - Single Bright Invalid
Cost Dim Neutral Dim - Single Dim Invalid
Congruence Benefit Dual By Dim - Dual by Bright
Dual Asymmetric Cost Bright Single Bright Valid - Dual by Bright
Dual Asymmetric Cost Dim Single Dim Valid - Dual by Dim
Dim Better Than Nothing Single Bright Invalid - Dual by Dim
Note. The RT differences between the primary measures in the second column
are used to calculate the derived measure in the first column.
doi:10.1371/journal.pone.0030731.t005
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PCR using the BigDye
TM sequencing reaction mix (Applied
Biosystems, CA). The sequencing PCR products were purified
using the BigDye XTerminator kit (Applied Biosystems, CA) and
then loaded on an ABI3730xl sequencing instrument using the
Rapid36 run module. The DNA sequencing results were analyzed
using the Mutation Surveyor software (SoftGenetics, PA).
In the case of the DAT1 (SL6A3) exon 8 polymorphism,
genotyping was performed using methods for microsatellite repeat
polymorphisms. The fluorescently labeled PCR products were
generated with a fluorescently labeled primer (see Table 6). The
amplified products were analyzed on an ABI3130xl Genetic
Analyzer. The Genemapper 4.0 software was used to assign the
allele distribution (Applied Biosystems).
To assess the reliability of the genotyping, we had seven of the
participants submit second saliva samples. These samples were
treated identically to all of the other samples, and the lab doing the
genotyping did not know that they were duplicates of existing
saliva samples. The agreement between the two genotyping runs
was 97.5% (78 of 80 alleles agreed). Two subjects contributed 10
alleles, and five subjects contributed 12 alleles to the reliability
analysis. Each of the two subjects who contributed 10 alleles could
not be genotyped on one genetic marker.
Table 6. Sequences for Polymorphisms Analyzed.
Polymorphism Strand Primer sequence
SL6A3 repeat (DAT1) Sense 59-TGTGTGCGTGCATGTGGa
Antisense 59-GCTTGGGGAAGGAAGGG
rs1108580 (DBH) Sense 59-ACGCCTGGAGTGACCAGAAG
Antisense 59-CCATCCTCCTTGGCTTTCTC
rs429358 (APOE) Sense 59-GAACTGGAGGAACAACTGAC
Antisense 59-CGCTCGCGGATGGCGCTGA
rs7412 (APOE) Sense 59-GAACTGGAGGAACAACTGAC
Antisense 59-CGCTCGCGGATGGCGCTGA
rs4680 (COMT) Sense 59-GCTACTCAGCTGTGCGCATG
Antisense 59-ACGTGGTGTGAACACCTGGT
rs747302 (DRD4) Sense 59-CGGAGGGAATGGAGGAGGGA
Antisense 59-AGACCTGAGCTCAGGCTCTG
Note.
aPrimer with 59-Fam fluorescent label.
doi:10.1371/journal.pone.0030731.t006
Figure 6. Derived measures by ethnicity. Overall, patterns are similar and statistical decisions were unchanged whether or not ethnicity was
used as a factor in the ANOVA. Note that some ethnicities do differ significantly from other ethnicities on particular outcome measures. AB=Alert
Bright; AD=Alert Dim; BB=Benefit Bright; BD=Benefit Dim; CB=Cost Bright; CD=Cost dim; DACB=Dual Asymmetric Cost Bright; DACD=Dual
Asymmetric Cost dim; CongB=Congruence Benefit; DTBN=Dim Better Than Nothing. Error bars are +/21 SEM.
doi:10.1371/journal.pone.0030731.g006
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We followed the advice of Hutchison, Stallings, McGeary and
Bryan [16] to address potential stratification artifacts by using self-
reported ethnicity as a proxy for genetic subpopulation. Several of
the derived measures showed significant differences by ethnicity
(see Figure 6), so we controlled statistically for self-reported
ethnicity in all of the genetic associations analyses below. To
classify the twelve individuals who reported dual ethnicities, we
compared their genetic data to the proportions of those genotypes
in our data set and classified each individual into the single
ethnicity with which their genetic data were most similar. One
individual could not be classified into a single ethnicity in this way,
so their data were not used in our analyses.
We followed up the significant MANCOVA (see the Results
section) with more focused univariate analyses. For each measure,
an initial ANOVA was used with ethnicity as an independent
variable to control statistically for possible population stratification
artifacts. To test for genetic associations, genotype was then added
as another independent variable, and the incremental R
2 was
obtained. Our statistical decisions were unchanged whether or not
ethnicity was used as a factor in the ANOAVA. Adding age as a
covariate did not change any statistical decisions. We entered
genes as predictors in separate models. We did not examine
possible epistatic effects (gene6gene interactions) because our
sample size was too small to detect these possible effects [51]. In
the genetic analyses, the useable sample size of 137 subjects was
further reduced because some subjects could not be genotyped at a
particular marker. Genotype was entered with df=1 to test for the
linear dose/response association (slope) between the number of
risk alleles (0, 1, or 2) and the phenotype. This is logical if the
increasing dose of a protein produced by an allele leads to
progressively more or less neurotransmitter availability. There are
studies, however, that suggest other patterns such as dominance
effects [35,52]. We only tested for linear genotype effects because
we did not have specific hypotheses about dominance-type effects
for any of the markers.
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